Allergic rhinitis as a systemic disease of respiratory tract

Jasiukiewicz Eleni, Fabian-Danielewska Anna, Piątek Patrycja. Allergic rhinitis as a systemic disease of respiratory tract. Journal of Education, Health and Sport. 2019;9(5):155-160. eISSN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.2741698 http://ojs.ukw.edu.pl/index.php/johs/article/view/6893 The journal has had 7 points in Ministry of Science and Higher Education parametric evaluation. Part B item 1223 (26/01/2017). 1223 Journal of Education, Health and Sport eISSN 2391-8306 7 © The Authors 2019; This article is published with open access at Licensee Open Journal Systems of Kazimierz Wielki University in Bydgoszcz, Poland Open Access. This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author (s) and source are credited. This is an open access article licensed under the terms of the Creative Commons Attribution Non commercial license Share alike. (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non commercial use, distribution and reproduction in any medium, provided the work is properly cited. The authors declare that there is no conflict of interests regarding the publication of this paper. Received: 28.04.2019. Revised: 28.04.2019. Accepted: 11.05.2019. Allergic rhinitis as a systemic disease of respiratory tract Eleni Jasiukiewicz¹, Anna Fabian-Danielewska¹,², Patrycja Piątek² NZOZ Przychodnia Medycyny Rodzinnej, ul. Kadłubka 10-11, Szczecin Pomorski Uniwersytet Medyczny w Szczecinie, Studium Doktoranckie Wydziału Lekarskiego Summary Allergic rhinitis affects nearly 500 million people in the world and is now considered not only to be a local catarrh of the nasal passages, but a chronic systemic respiratory disease. Proof of generalization of this process is the frequent coexistence of asthma and allergic rhinitis. In recognition, the most important role is played by, first of all, a well-collected interview and physical examination. Treatment depends on the form of AR (periodic or chronic) and on the severity of symptoms (mild, moderate or severe). The first-line drugs are nasal glucocorticosteroids and second generation antihistamines. Appropriate treatment allows to reduce ailments and avoid complications, including upper (sinusitis, exudative otitis media, tonsillitis) and lower respiratory tract (bronchial hyperresponsiveness, bronchial asthma), which significantly reduce the quality of life of patients (QOL). Key words: Allergy; Rhinitis; Asthma; Atopic